Kurtis

MOTORTREND CELBRATES DIAMOND ANNIVERSARY WITH CALL TO VOTE FOR THE SINGLE MOST ICONIC VEHICLE OF THE PAST 75 YEARS

Retrieved on: 
Tuesday, December 12, 2023
Diamond, BMW, BMW 3 Series, Ford, Ultimate, Phillumeny, Price action trading, Diamond jubilee, Motor Trend Group, Porsche, Decade, Collection, Performance, Warner Bros. Discovery, Lamborghini, History, Most, LOS, Mattel Television, Ford Mustang Mach-E, McKeel Hagerty, Kurtis Sport Car, SUV, Haulage, Volkswagen, Sports car, Mustang, Kurtis, Growth, Beetle, Trusted Media Brands, F-150, EV, Discovery, Lamborghini Countach, Model, Warner Bros., Free, Automotive industry, Road, Teahouse

LOS ANGELES, Dec. 12, 2023 /PRNewswire/ -- MotorTrend Group, a Warner Bros. Discovery company, today announced the brand's year-long celebration of a momentous 75th anniversary year in 2024. Kicking off with a public call to vote on the most legendary vehicle in the MotorTrend 75 Icons program, the celebration continues with special-edition collectibles, 75th anniversary merchandise, and the historically significant release of MotorTrend's full archives in digital format for the first time ever.

Key Points: 
  • As MotorTrend approaches its Diamond Anniversary, the media company and automotive industry leader is pulling out all the stops to honor its history.
  • MotorTrend's editorial team has meticulously selected 10 of the most iconic vehicles from the past 75 years, naming them 'MotorTrend 75 Icons'.
  • Now, MotorTrend invites the public to determine the single most iconic vehicle from the past 75 years, inviting active participation in this historic celebration.
  • For a limited time, MotorTrend is making the entire archive freely available to the public to celebrate the Diamond Anniversary.

Ocean Biomedical (NASDAQ: OCEA) Details Novel Malaria Therapeutic Discoveries at the NIH Laboratory of Malaria Vaccinology and Immunology on PfGARP’s Potential as a Highly Effective Vaccine Target and Therapeutic Candidate to Treat Malaria

Retrieved on: 
Tuesday, March 21, 2023
Drug development, Therapy, Parasitism, Climate, Medical laboratory, Kurtis, Ocean Biomedical, RI, CHI3L1, University, World Health Organization, DRS, Research, Doctor of Philosophy, Biology, Glioblastoma, Vaccine, Death, Science, MD, Pathology, Brown University, Parasitemia, Immunology, Artemisinin, Family, Alpert Medical School, NIH, Pharmaceutical industry, Medical device, Malaria, Medicine

Developments shared at the meeting detail how Dr. Kurtis’ team used a novel approach to capitalize on PfGARPs ability to kill parasites, targeting it for potential drug development.

Key Points: 
  • Developments shared at the meeting detail how Dr. Kurtis’ team used a novel approach to capitalize on PfGARPs ability to kill parasites, targeting it for potential drug development.
  • Dr. Elias is Ocean Biomedical’s other Scientific Co-founder and Dean Emeritus of Medicine and Biological Sciences at Brown University.
  • This differential screening technique has led to the discovery of three key targets that are being formulated into a highly effective malaria vaccine candidate being advanced by Dr. Kurtis and Ocean Biomedical.
  • This discovery has allowed Ocean Biomedical to begin simultaneously pursuing the development of a novel malaria vaccine, and novel malaria therapeutics.